| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |